Schedule 13G ownership disclosure

Clearside Biomedical, Inc.

Security class unavailable

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-19-000263
Form type
SC 13G
Filer
Clearside Biomedical, Inc.
CIK
CIK 1539029
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub